Rekah Pharmaceutical Industry Ltd. (REKA.TA)
ILA 1409.0
(-0.14%)
ILA 1409.0
(-0.14%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 79.67 Million ILS | 25.4% |
| 2022 | 63.53 Million ILS | 23.44% |
| 2021 | 51.47 Million ILS | 9.93% |
| 2020 | 46.82 Million ILS | -3.36% |
| 2019 | 48.44 Million ILS | -7.47% |
| 2018 | 52.35 Million ILS | -5.06% |
| 2017 | 55.14 Million ILS | -7.47% |
| 2016 | 59.6 Million ILS | -20.82% |
| 2015 | 75.27 Million ILS | 23.54% |
| 2014 | 60.93 Million ILS | -23.7% |
| 2013 | 79.85 Million ILS | 11.27% |
| 2012 | 71.76 Million ILS | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 19.95 Million ILS | -4.93% |
| 2024 Q2 | 18.51 Million ILS | -120.05% |
| 2023 Q2 | 19.05 Million ILS | 17.13% |
| 2023 Q1 | 16.26 Million ILS | 3.5% |
| 2023 Q4 | 20.98 Million ILS | 3.95% |
| 2023 FY | 79.67 Million ILS | 25.4% |
| 2023 Q3 | 20.19 Million ILS | 5.97% |
| 2022 Q3 | 16.42 Million ILS | 2.15% |
| 2022 FY | 63.53 Million ILS | 23.44% |
| 2022 Q1 | 15.32 Million ILS | 4.86% |
| 2022 Q2 | 16.07 Million ILS | 4.91% |
| 2022 Q4 | 15.71 Million ILS | -4.28% |
| 2021 Q1 | 11.62 Million ILS | 10.14% |
| 2021 Q4 | 14.61 Million ILS | 17.27% |
| 2021 Q3 | 12.46 Million ILS | -2.25% |
| 2021 FY | 51.47 Million ILS | 9.93% |
| 2021 Q2 | 12.74 Million ILS | 9.69% |
| 2020 Q2 | 11.63 Million ILS | -9.03% |
| 2020 Q1 | 12.78 Million ILS | 2.26% |
| 2020 FY | 46.82 Million ILS | -3.36% |
| 2020 Q4 | 10.55 Million ILS | -10.78% |
| 2020 Q3 | 11.82 Million ILS | 1.69% |
| 2019 Q1 | 13.15 Million ILS | -1.67% |
| 2019 FY | 48.44 Million ILS | -7.47% |
| 2019 Q4 | 12.5 Million ILS | 4.58% |
| 2019 Q3 | 11.95 Million ILS | 1.6% |
| 2019 Q2 | 11.76 Million ILS | -10.54% |
| 2018 Q4 | 13.37 Million ILS | 6.18% |
| 2018 FY | 52.35 Million ILS | -5.06% |
| 2018 Q1 | 13 Million ILS | -6.11% |
| 2018 Q2 | 13.38 Million ILS | 2.9% |
| 2018 Q3 | 12.59 Million ILS | -5.86% |
| 2017 FY | 55.14 Million ILS | -7.47% |
| 2017 Q1 | 13.59 Million ILS | -9.58% |
| 2017 Q2 | 13.98 Million ILS | 2.84% |
| 2017 Q3 | 13.71 Million ILS | -1.9% |
| 2017 Q4 | 13.85 Million ILS | 0.96% |
| 2016 Q2 | 14.03 Million ILS | -8.63% |
| 2016 FY | 59.6 Million ILS | -20.82% |
| 2016 Q1 | 15.36 Million ILS | 2248.93% |
| 2016 Q4 | 15.03 Million ILS | -0.83% |
| 2016 Q3 | 15.16 Million ILS | 8.03% |
| 2015 FY | 75.27 Million ILS | 23.54% |
| 2015 Q4 | 654 Thousand ILS | -96.6% |
| 2015 Q3 | 19.23 Million ILS | 0.25% |
| 2015 Q2 | 19.18 Million ILS | 3.19% |
| 2015 Q1 | 18.59 Million ILS | -5.98% |
| 2014 Q2 | 18.09 Million ILS | -6.29% |
| 2014 Q4 | 19.77 Million ILS | -1.26% |
| 2014 FY | 60.93 Million ILS | -23.7% |
| 2014 Q3 | 20.02 Million ILS | 10.68% |
| 2014 Q1 | 19.3 Million ILS | 67.81% |
| 2013 FY | 79.85 Million ILS | 11.27% |
| 2013 Q2 | 18.37 Million ILS | 24.14% |
| 2013 Q3 | 16.43 Million ILS | -10.58% |
| 2013 Q4 | 11.5 Million ILS | -29.98% |
| 2013 Q1 | 14.8 Million ILS | -10.15% |
| 2012 Q4 | 16.47 Million ILS | -12.21% |
| 2012 Q3 | 18.76 Million ILS | 0.0% |
| 2012 FY | 71.76 Million ILS | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Cannabotech LTD | 15.36 Million ILA | -418.441% |